SCHEMBL23902506

SCHEMBL23902506

CC(C)(C)OC(=O)N1C(=O)CC(=O)C2CCCC21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.39
CHRM1 P11229 1/20 0.39
CHRM3 P20309 1/20 0.39
EPHX1 P07099 1/20 0.37
HPGD P15428 1/20 0.35
KDM4E B2RXH2 1/20 0.34
MAPT P10636 1/20 0.34
THRB P10828 1/20 0.34
DDB1 Q16531 2/20 0.34
CRBN Q96SW2 2/20 0.34
PREP P48147 1/20 0.33
BTK Q06187 1/20 0.33
OPRK1 P41145 1/20 0.32
GPR119 Q8TDV5 2/20 0.32
ELANE P08246 1/20 0.32
HSD11B1 P28845 1/20 0.32
PDE4A P27815 1/20 0.32
PDE4B Q07343 1/20 0.32
PDE4C Q08493 1/20 0.32
PDE4D Q08499 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23902504 1.00 CHRM2 (0.39) CHRM2CHRM1CHRM3EPHX1HPGD
SCHEMBL12565056 0.81 EPHX1 (0.40) CHRM2CHRM1CHRM3EPHX1HPGD
SCHEMBL13253756 0.81 EPHX1 (0.40) CHRM2CHRM1CHRM3EPHX1HPGD
SCHEMBL19217727 0.77 EPHX1 (0.46) CHRM2CHRM1CHRM3EPHX1HPGD
SCHEMBL2196268 0.77 CHRM2 (0.41) CHRM2CHRM1CHRM3HPGDKDM4E
SCHEMBL9047135 0.77 EPHX1 (0.39) CHRM2CHRM1CHRM3EPHX1HPGD
SCHEMBL3733204 0.77 CHRM2 (0.41) CHRM2CHRM1CHRM3EPHX1HPGD
SCHEMBL19217730 0.77 EPHX1 (0.46) CHRM2CHRM1CHRM3EPHX1HPGD
SCHEMBL2196261 0.77 CHRM2 (0.41) CHRM2CHRM1CHRM3HPGDKDM4E
SCHEMBL20735039 0.76 CHRM2 (0.40) CHRM2CHRM1CHRM3HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021198020-A1 3-(ANILINO)-2-[3-(3-ALKOXY-PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER BAYER AKTIENGESELLSCHAFT (DE) 2021-10-07 WO disclosed